Invention Grant
US07709463B2 Idraparinux (SanOrg34006) for treatment of venous events in patients with deep venous thrombosis
失效
用于治疗深静脉血栓形成患者静脉血栓栓塞事件的Idraparinux（SanOrg34006）
- Patent Title: Idraparinux (SanOrg34006) for treatment of venous events in patients with deep venous thrombosis
- Patent Title (中): 用于治疗深静脉血栓形成患者静脉血栓栓塞事件的Idraparinux（SanOrg34006）
-
Application No.: US10502706Application Date: 2003-01-23
-
Publication No.: US07709463B2Publication Date: 2010-05-04
- Inventor: Ronald Gijsbertus Maria Van Amsterdam
- Applicant: Ronald Gijsbertus Maria Van Amsterdam
- Applicant Address: FR Paris
- Assignee: Sanofi-Aventis
- Current Assignee: Sanofi-Aventis
- Current Assignee Address: FR Paris
- Agent Ronald G. Ort; James W. Bolcsak
- Priority: EP002075374 20020129
- International Application: PCT/EP03/00696 WO 20030123
- International Announcement: WO03/063881 WO 20030807
- Main IPC: A61K31/715
- IPC: A61K31/715 ; A61K31/737 ; A61K31/7028 ; A61K31/70
Abstract:
The invention relates to a dose of 2.5 mg of the pentasaccharide methyl O-(2,3,4-tri-O-methyl-6-O-sulfo-α-D-glucopyranosyl)-(1→4)-O-(2,3-di-O-methyl-β-D-glucopyranosyl uronic acid)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glucopyranosyl)-(1→4)-O-(2,3-di-O-methyl-α-L-idopyranosyl uronic acid)-(1→4)-2,3,6-tri-O-sulfo-α-D-glucopyranoside or a pharmaceutically acceptable salt thereof for use in therapy, in particular for the treatment of venous thromboembolic events in patients with deep venous thrombosis.
Public/Granted literature
Information query
